An AdvanceBio HIC Column for Drug‑to-Antibody Ratio (DAR) Analysis of Antibody Drug Conjugates (ADCs)

Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes Application compendium Contents Introduction3 Featured application notes 2 PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mAbs and ADC (5991-7163EN) 5 Intact- and Peptide-Level Characterization of Trastuzumab Emtansine In Vitro…

Sandeep kondaveetil1, Andy Coffey2, Priya Jayaraman1, Linda Llyod2, Suma Ramagiri1 Hydrophobic Interaction Chromatography- Native Mode Separation of Bio-Therapeutic Workflows 1. Agilent Technologies, Inc., Wilmington, DE USA 2. Agilent Technologies, Inc., Church Stretton, UK Experimental LC Conditions – mAb oxidized variant…

Consumables Workflow Ordering Guide Improving the Quality of Antibody Drug Conjugates by Orthogonal Analytical Methods Antibody Drug Conjugates Antibody-drug conjugates (ADCs) represent a new generation of targeted biotherapeutics that make up a rapidly growing segment of the drug discovery pipeline.…

Application Note Biopharma/Pharma Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS Authors David L. Wong and Sarah M. Stow Agilent Technologies, Inc. Abstract Antibody drug conjugates (ADCs), which comprise a monoclonal antibody (mAb) conjugated to a small molecule drug…